LabCorp to Present at the UBS Global Life Sciences Conference

BURLINGTON, N.C., Sept. 28 /PRNewswire-FirstCall/ -- Laboratory Corporation of America(R) Holdings (LabCorp(R)) (NYSE: LH) today announced that Thomas P. Mac Mahon, Chairman and Chief Executive Officer, is scheduled to speak at the UBS Global Life Sciences Conference in New York, NY.

LabCorp(R) Launches Comparative Genomic Hybridization Testing

BURLINGTON, N.C., Sept. 21 /PRNewswire-FirstCall/ -- Laboratory Corporation of America(R) Holdings (LabCorp(R)) (NYSE: LH) announced today that it will begin offering Comparative Genomic Hybridization (CGH), a revolutionary new technology that provides physicians with the information necessary to

LabCorp Launches Its eLabCorp(SM) Web-Based Customer Connectivity Solution

BURLINGTON, N.C., Sept. 15 /PRNewswire-FirstCall/ -- Laboratory Corporation of America(R) Holdings (LabCorp(R)) (NYSE: LH) today announced the launch of "eLabCorp," its latest customer connectivity offering. eLabCorp has been designed to provide LabCorp customers with unparalleled compatibility and

LabCorp to Present at The Thomas Weisel Partners Healthcare Conference

BURLINGTON, N.C., Sept. 1 /PRNewswire-FirstCall/ -- Laboratory Corporation of America(R) Holdings (LabCorp(R)) (NYSE: LH) today announced that Bradford T. Smith, Executive Vice President, Corporate Affairs, and William (Brad) Hayes, Executive Vice President and Chief Financial Officer, are

LabCorp(R) to Begin Validation and Evaluation of Roche Diagnostics' AmpliChip(TM) CYP450 Test

BURLINGTON, N.C., July 22 /PRNewswire-FirstCall/ -- Laboratory Corporation of America(R) Holdings (LabCorp(R)) (NYSE: LH) announced today that it will begin validation testing of Roche Diagnostics' AmpliChip(TM) CYP450 test. The AmpliChip(TM) CYP450 test has been cleared by the U.S.

Laboratory Corporation of America(R) Announces 2005 Second Quarter Results

Revenue Increase of 8.8 Percent Drives EBITDA Margin of 26.4 Percent and EPS Increase of 12.1 Percent BURLINGTON, N.C., July 21 /PRNewswire-FirstCall/ -- Laboratory Corporation of America(R) Holdings (LabCorp(R)) (NYSE: LH) today announced results for the quarter and six-months ended June 30, 2005.

LabCorp(R) Scheduled To Present at the Banc of America Securities Healthcare Conference

BURLINGTON, N.C., May 17 /PRNewswire-FirstCall/ - Laboratory Corporation of America(R) Holdings (LabCorp(R)) (NYSE: LH) today announced that Thomas P. Mac Mahon, Chairman and Chief Executive Officer, is scheduled to speak at the Banc of America Securities Healthcare Conference in Las Vegas, NV on

LabCorp(R) Scheduled To Webcast Its Annual Meeting Of Stockholders

BURLINGTON, N.C., May 17 /PRNewswire-FirstCall/ -- Laboratory Corporation of America(R) Holdings (LabCorp(R)) (NYSE: LH) today announced that its Annual Meeting of Shareholders will be webcast live beginning May 18, 2005 at 9:00 a.m. Eastern Time via the Company web site at www.labcorp.com .

LabCorp(R) Completes Acquisition of Esoterix, Inc.

BURLINGTON, N.C., May 11 /PRNewswire-FirstCall/ -- Laboratory Corporation of America(R) Holdings (LabCorp(R)) (NYSE: LH) today announced it has completed its previously announced acquisition of Esoterix, Inc. and subsidiaries, a leading provider of specialty reference testing.

LabCorp(R) Announces Stock Repurchase Program

BURLINGTON, N.C., May 3 /PRNewswire-FirstCall/ -- Laboratory Corporation of America(R) Holdings (LabCorp(R)) (NYSE: LH) today announced that its Board of Directors has authorized a new stock repurchase program under which LabCorp may purchase up to an aggregate of $250,000,000 of its Common Stock